Molecular Templates
Austin
About Molecular Templates
Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases. It primarily develops a pipeline of therapies through its proprietary biologic-engineered toxin body (ETB) drug platform with unique mechanisms of action which are highly differentiated from antibody-drug conjugates (ADCs).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $397.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2024)
- Ticker: nasdaq:MTEM
- Website: mtem.com
- Phone: 5122332709
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/molecular-templates-9187 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.